A Prospective, Post-Market, Multicenter Trial (CHEETAH) Suggested TearCare® System as a Safe and Effective Blink-Assisted Eyelid Device for the Treatment of Dry Eye Disease.

Paul M KarpeckiDavid WirtaSmajo OsmanovicKavita Dhamdhere

Published in: Clinical ophthalmology (Auckland, N.Z.) (2020)

These results suggest that single TearCare procedure is safe and effective in treating signs/symptoms of DED. Significant improvements were seen in all subjects (100%) in all signs and symptoms of DED within 1-week of treatment and 83% subjects experienced clinically meaningful symptom relief. Additionally, TearCare seems to be effective in treating DED associated with all severities of meibomian gland obstruction.

Keyphrases

clinical trial
randomized controlled trial
cross sectional
study protocol
sleep quality
minimally invasive
health insurance